Frolov A - Search Results

1

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, Thompson TC, Harper JW. Yang G, et al. Among authors: frolov a. Clin Cancer Res. 2002 Nov;8(11):3419-26. Clin Cancer Res. 2002. PMID: 12429629

2

Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.

Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC. Satoh T, et al. Among authors: frolov a. Cancer. 2003 Mar 1;97(5):1225-33. doi: 10.1002/cncr.11198. Cancer. 2003. PMID: 12599229 Free article.

3

Expression of neutral amino acid transporter ASCT2 in human prostate.

Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, Ayala G. Li R, et al. Among authors: frolov a. Anticancer Res. 2003 Jul-Aug;23(4):3413-8. Anticancer Res. 2003. PMID: 12926082

4

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC. Tahir SA, et al. Among authors: frolov a. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9. Clin Cancer Res. 2003. PMID: 14506154

5

The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. Ayala G, et al. Among authors: frolov a. Cancer Res. 2003 Oct 1;63(19):6244-51. Cancer Res. 2003. PMID: 14559810

6

Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J, Rowley DR. Ayala G, et al. Among authors: frolov a. Clin Cancer Res. 2003 Oct 15;9(13):4792-801. Clin Cancer Res. 2003. PMID: 14581350

7

Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.

Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A, Ayala G. Li R, et al. Among authors: frolov a. Prostate. 2004 Feb 1;58(2):193-9. doi: 10.1002/pros.10321. Prostate. 2004. PMID: 14716745

8

Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression.

Yang G, Addai J, Tian WH, Frolov A, Wheeler TM, Thompson TC. Yang G, et al. Among authors: frolov a. Cancer Res. 2004 Mar 15;64(6):2076-82. doi: 10.1158/0008-5472.can-03-4072. Cancer Res. 2004. PMID: 15026346

9

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.

Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. Li R, et al. Among authors: frolov a. Am J Surg Pathol. 2004 Jul;28(7):928-34. doi: 10.1097/00000478-200407000-00013. Am J Surg Pathol. 2004. PMID: 15223964

10

Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival.

McAlhany SJ, Ayala GE, Frolov A, Ressler SJ, Wheeler TM, Watson JE, Collins C, Rowley DR. McAlhany SJ, et al. Among authors: frolov a. Prostate. 2004 Oct 1;61(2):182-91. doi: 10.1002/pros.20085. Prostate. 2004. PMID: 15305341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

835 results

Search Page

Filters